Riskpilot← Back to searchSign inGet full accessScientificMed Tech AB
ABActiveOrg 5569074874StockholmComputer programming activities · NACE 6210Est. 20120 employees
Revenue 2024
SEK 200K
-41% vs 2023
EBITDA margin
-7.0%
+33% vs 2023
Equity ratio
53.6%
Financial strength
Net profit 2024
SEK -32K
-39% vs 2023
| Revenue | SEK 200K | -41% |
| EBITDA | SEK -14K | +33% |
| Net profit | SEK -32K | -39% |
| Total assets | SEK 2,2M | -17% |
| Equity | SEK 1,2M | -3% |
| Employees | 0 | — |
Legal name
ScientificMed Tech AB
Org number
5569074874
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
22 oktober 2012
Share capital
SEK 73 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Cederqvist, Carl Johan Henrik Firman tecknas i förening av ledamöterna
Company purpose
Bolaget ska bedriva konsultverksamhet inom affärsutveckling, IT, hälsovård och läkemedel, bedriva tjänste- och produkt- utveckling, speciellt inom områdena IT, telekommunikation och medicinteknik, bedriva handel med värdepapper och fast egendom samt därmed förenlig verksamhet.
Address
Stockholm
Email
contact@scientificmed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 4 696 | 3 373 | 2 953 | 1 837 | 1 374 | 1 318 | 340 | 200 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 12 | 311 | 1 314 | 664 | −3 633 | −2 226 | −1 381 | −3 | −21 | −14 |
| Depreciation & amort. | −0 | −173 | −446 | −781 | −1 124 | −1 548 | −1 824 | −1 561 | −0 | −0 |
| EBIT | 12 | 138 | 868 | −117 | −4 757 | −3 774 | −3 205 | −1 564 | −21 | −14 |
| Net financials | −4 | −30 | −55 | −78 | −122 | −61 | −31 | — | −2 | −18 |
| Profit before tax | 8 | 80 | 613 | 4 | −4 816 | −3 835 | −3 236 | −1 564 | −23 | −32 |
| Tax | −3 | −20 | −136 | −4 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 5 | 60 | 477 | 0 | −4 816 | −3 835 | −3 236 | −1 564 | −23 | −32 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 816 | 3 717 | 4 301 | 8 835 | 10 102 | 6 570 | 5 794 | 2 673 | 2 641 | 2 183 |
| Equity | 65 | 124 | 601 | 5 110 | 6 478 | 2 852 | 2 787 | 1 223 | 1 200 | 1 169 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 751 | 3 564 | 3 471 | 3 695 | 3 624 | 3 718 | 3 008 | 1 450 | 1 441 | 1 015 |
| Total debt | 1 751 | 3 564 | 3 471 | 3 695 | 3 624 | 3 718 | 3 008 | 1 450 | 1 441 | 1 015 |
EBITDA margin
-7.0%
This company
15.8%
Market median
-144% vs market
20152024
Equity ratio
53.6%
This company
38.2%
Market median
+40% vs market
20152024
Return on equity
-2.7%
This company
18.4%
Market median
-115% vs market
20152024
Net profit margin
-16.0%
This company
8.1%
Market median
-298% vs market
20152024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20152024
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VJ Chief Auditor | Chief Auditor | 2025 | — | — |
JA Chief Auditor | Chief Auditor | 2022 | — | — |
SE Chief Auditor | Chief Auditor | 2020 | — | — |
CJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cuviva AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cuviva AB
ScientificMed Tech AB Board members of ScientificMed Tech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Victor John Cukierman | Chief Auditor | 0 companies |
| Johan Anders Frederik Edman | Chief Auditor | 0 companies |
| Serhat Eliacik | Chief Auditor | 0 companies |
| Carl Johan Henrik Cederqvist | Chief Executive Officer | 0 companies |
| Eva Ruth Cederqvist | Deputy Board Member | 0 companies |
| Björn Johan Cederlund | Deputy Board Member | 0 companies |
| Josefin Christina Landgård | Board of Directors | 0 companies |
| Carl Jonas Ahlén | Chairman | 0 companies |
| Lars Martin Olovsson | Board of Directors | 0 companies |
| Johan Åke Gunnar Bloom | Board of Directors | 0 companies |
| Jan Åke Sung Fjellström | Chairman | 0 companies |
| Fredrik Gustav Ingvar Koffner | Board of Directors | 0 companies |